Chair: Rajesh Pahwa, MD
Co-chair: Mark Stacy, MD
Bob Hauser, MD (USA)
Stuart Isaacson, MD (USA)
Fabrizio Stocchi, MD (Italy)
Wolfgang Oertel, MD (Germany)
Werner Poewe, MD (Austria)
Irene Litvan, MD (USA)
Carllie Tanner, MD (USA)
Fernando Pagan, MD (USA)
Carey Christensen (USA)
Patricia Davies (USA)
Elizabeth Pollard (USA)
Karen Northrop (USA)
Rajesh Pahwa, MD is a Professor in the Department of Neurology and Director of the Parkinson’s Disease and Movement Disorder Center at the University of Kansas School of Medicine in Kansas City.
Upon attainment of his MBBS (MD) degree at Seth G.S. Medical College, University of Bombay, India, Dr. Pahwa completed an internship in medicine at Baylor College of Medicine followed by a residency in Neurology at Baylor College of Medicine, Houston, Texas. He then completed a one-year fellowship in movement disorders at the University of Kansas Medical Center before joining the faculty of the Department of Neurology as an Instructor in 1992.
Dr. Pahwa is a Diplomat of the American Board of Psychiatry and Neurology. His research interests are centered around the various aspects of Parkinson’s disease and essential tremor. He is currently involved in various studies related to medical and surgical forms of therapies for Parkinson’s disease and essential tremor. Dr. Pahwa has published over 100 peer-reviewed articles. In addition he has published numerous chapters and abstracts in leading neurology and movement disorder journals. He has conducted over 50 clinical trials related to Parkinson’s disease and other movement disorders. He is the co-editor of "Handbook of Parkinson’s Disease,” 3rd and 4th editions, "Therapy of Parkinson's Disease," 3rd edition, "Handbook of Essential Tremor and other Tremor Disorders,” 1st edition, and co-author of the book "Parkinson’s Disease: Questions and Answers,” 4th edition. He is also the Co-Editor in Chief of the International Journal of Neuroscience. He is also an active member of American Academy of Neurology, American Neurological Association, Movement Disorder Society, Kansas City Neurology Neurosurgery Society, Parkinson Study Group, and Tremor Research Group.
Mark Stacy, MD was appointed Vice Dean for Clinical Research in November of 2011.
Dr. Stacy is a highly respected clinical investigator and a talented administrator who served as Associate Dean for Clinical Research since 2009. He has been a key driver in improving Duke's clinical research practice and in developing the site-based research director community. Dr. Stacy serves as a liaison between the Dean’s office and the Clinical Department Chairs and faculty. His duties include implementation of programs to support the clinical research mission, and oversight of the Institutional Review Board (IRB), conflict of interest (COI), and clinical research administration activities.
As Vice Dean for Clinical Research, Dr. Stacy works in partnership with the Vice Dean for Basic Science to provide support and guidance for translational research.
Dr. Stacy joined Duke in 2003, and is a professor of medicine in the Division of Neurology, and director of the Duke Movement Disorders Center. He served as director of the Neurology Clinical Research Organization prior to moving to the Dean's Office. His clinical and research interests are concentrated on signs, symptoms and treatment of Parkinson’s disease, specifically: motor and non-motor symptoms of wearing off, pathological gambling and other impulse-control disorders, and placebo effect in clinical trials. He has served as an advisor to a number of pharmaceutical and device manufacturers that lead to the approval of products to better treat this condition, and has participated in more than 100 clinical trials. He also serves as advisor and consultant on numerous national and community committees, including WE MOVE, the Parkinson Study Group, the Dystonia Study Group, the National Parkinson Foundation, and the American Academy of Neurology. Prior to his arrival at Duke he served as the director of the Muhammad Ali Parkinson Research Center in Phoenix, Arizona. He is the co-editor of Moving Along, the newsletter of the Movement Disorders Society.
Dr. Stacy has published numerous peer-reviewed manuscripts, book chapters, and review articles on the topics of Parkinson’s disease, dystonia, tremor, and other movement disorders. He is also the editor of The Handbook of Dystonia.
Bob Hauser, MD obtained his medical degree from Temple University School of Medicine, and performed his neurology training at the Eastern Virginia Graduate School of Medicine. He then completed a fellowship in Movement Disorders at the University of South Florida. His research focus is the development of new treatments for Parkinson’s disease and other movement disorders. His areas of expertise include clinical trials design and execution, and evaluation of emerging medical and surgical therapies for Parkinson’s disease.
Dr. Hauser is Director of the Signature Interdisciplinary Clinical Research Program in Neuroscience at the University of South Florida. He is Past Chairman of the Interventional Neurology Section of the American Academy of Neurology and previously served on the executive committee of the Section of Movement Disorders. He is currently a member of the executive committee of the Parkinson Study Group and the steering committee of the NIH Exploratory Trials in Parkinson’s Disease (NET-PD) program.
Dr. Hauser has authored or co-authored over 100 peer reviewed publications. He currently serves as lead investigator or as a member of the steering committee for multiple national and international clinical trials. He lectures frequently at scientific meetings and has been selected to Chair the 18th International Congress on Parkinson’s Disease and Related Disorders in Miami, Florida in 2009.
Stuart Isaacson, MD is Clinical Associate Professor of Neurology at the FIU Herbert Wertheim College of Medicine. Dr. Isaacson received his medical degree from Northwestern University School of Medicine in Chicago, Illinois. He completed fellowships at the National Institutes of Health in Bethesda Maryland, and in NY at the Mount Sinai Medical Center under Warren Olanow, Melvin Yahr, and Mitchell Brin. In 1999, Dr. Isaacson established the Parkinson’s Disease and Movement Disorders Center of Boca Raton, where he directs a team of movement disorder neurologists and clinical coordinators combining a holistic approach to medical therapy with access to state-of-the-art clinical research trials to find new treatments and ultimately a cure for Parkinson’s disease and related movement disorders. He has been involved in over 100 clinical trials and has served on national and international committees for many drug development programs and trials, as well as for the Parkinson Study Group and the Movement Disorders Section of the American Academy of Neurology. Dr. Isaacson has authored or co-authored nearly 200 abstracts, journal articles, and book chapters, and has presented research results at national and international scientific meetings. He has also worked closely with national foundations, including the Michael J. Fox Foundation for Parkinson’s Research. Dr. Isaacson is a member of the American Academy of Neurology, the Movement Disorders Society, the Section on Movement Disorders of the AAN, the Parkinson’s Study Group, the Huntington’s Study Group, and has been recognized in Best Doctors in America, America’s Top Physicians, and Florida SuperDoctors.
Fabrizio Stocchi, MD is a Professor of Neurology, Consultant in Neurology and Director of the Parkinson’s disease and Movement disorders research centre at the Institute for Research and Medical Care IRCCS San Raffaele Rome and University "La Sapienza” Rome. He is also Scientific advisor of the Institute for Parkinson’s Disease Research in Vicenza. Professor Stocchi was awarded his MD from the University of L’Aquila and his PhD from the University of Catania.
Professor Stocchi’s research activities have centred on neuropharmacology in the field of movement disorders and neurodegenerative diseases. He has published many books and papers on the genetics, clinical diagnosis, xtrapyramidal n and treatment of Parkinson’s disease, as well as in preclinical research into the disease. He is an active member of 11 societies, including the Movement Disorders Society, the WFN society where is member of the xtrapyramidal committee, the European Clinical Neuropharmacology Society and the European Federation Neurological Society.
Wolfgang Oertel, MD (Germany) obtained his MD at the University of Berlin, Germany. He completed his postgraduate neuroscience training at the Laboratory of Clinical Sciences at the National Institute of Mental Health, NIH, Bethesda, Maryland, USA.
He is full professor for neurology and director of the Department of Neurology at the Philipps University Marburg, Germany, a Centre of Excellence of the US National Parkinson Foundation. Wolfgang H. Oertel is currently speaker of the Competence Network on Parkinson’s Disease (an outstanding infrastructure for medical research in Germany) and chairman of the German Parkinson Study Group. In addition, he is president-elect of the German Society of Neurology and liaison professor of the German National Academic Foundation at the Philipps-University of Marburg. He received the Parkinson-Frosst Award (1986) and the Dingebaur-Price for Parkinson research (2004) from the German Society of Neurology and the “carrier award for basal ganglia disorders” from the German Research Foundation (1987-1990).
Dr. Oertel’s research interests focus on the diagnosis and treatment of neurodegenerative disorders (particularly Parkinson’s disease and atypical parkinsonian syndromes) as well as sleep disorders (especially REM-sleep-behaviour-disorder and restless-legs-syndrome). He has profound expertise in the design and conduct of diagnostic and therapeutical trials in these fields and has been principal investigator or co-principal investigator in numerous clinical trials.
Werner Poewe, MD (Austria) is a Professor of Neurology and the Director of the Department of Neurology at Innsbruck Medical University in Innsbruck, Austria. He held a Residency in Clinical Neurology and Psychiatry at the University of Innsbruck, Austria, from 1977 to 1984. Then, Professor Poewe was a British Council Research Fellow at University College and Middlesex Hospital Medical School, London. For three years (1986-1989), he was a Senior Lecturer in the Department of Neurology at the University of Innsbruck, Austria. From 1990 through 1994 he served as Professor of Neurology and Acting Director of the Department of Neurology at the Virchow Hospital of the Free University of Berlin. Professor Poewe’s main research interests are in the field of movement disorders with particular emphasis on the clinical pharmacology of Parkinson’s disease and dystonia. He has authored and co-authored more than 400 original articles and reviews in the field of movement disorders. He served as President of the International Movement Disorder Society from 2000 through 2002, as President of the Austrian Society of Neurology from 2002 to 2004 and is the current President of the Austrian Parkinson’s Disease Society.
Irene Litvan, MD (USA) is the Tasch Endowed Chair of Parkinson Disease Research at the University of California San Diego (UCSD), Professor of Neurosciences and Director of the UCSD Movement Disorder Center. She has published more than 230 peer-reviewed articles and chapters on the diagnosis of neurodegenerative parkinsonian and dementia disorders and its neuropsychiatric aspects. She was editor/senior editor of 4 books on atypical parkinsonian disorders and dementias including the first one solely dedicated to progressive supranuclear palsy and first one on corticobasal degeneration. Dr. Litvan is a reviewer for several medical, neurologic and neuropsychologic journals. She mentors master, PhD candidates, medical students, residents and fellows. Dr. Litvan is a fellow of the American Neurological Association and of the American Academy of Neurology. She serves and has served on many boards and committees. She is currently the chair of the MDS Pan American Section Education Committee, secretary of the World Federation of Neurology Research Group on Dementia and member of the medical scientific boards of CurePSP, PSP Europe Association and the Association for Frontotemporal Dementias. She received the National Institutes of Health merit award for leading international multicenter studies to evaluate and improve the clinical diagnostic criteria of several dementia and parkinsonian neurodegenerative disorders. She is the principal investigator of a National Institutes of Aging multisite and multidisciplinary study to identify the genetic and environmental risk factors for progressive supranuclear palsy. The scope of her research is translational in its nature.
Carllie Tanner, MD (USA) completed a residency in neurology and a fellowship in clinical neuropharmacology and movement disorders at Rush University and a doctorate in environmental health sciences at the University of California-Berkeley. Her clinical practice specializes in movement disorders, particularly Parkinson’s disease (PD), atypical parkinsonism and dystonia. Her research interests include investigations of descriptive epidemiology, environmental and genetic determinants, biomarkers, early detection, non-motor disease features and interventions for the secondary prevention, and disease modification and symptomatic treatment of movement disorders and neurodegenerative diseases. Her current research includes epidemiologic investigations of PD, multiple system atrophy, dystonia, Huntington’s disease, motor neuron disease, essential tremor and REM sleep behavior disorder in many populations, including the NAS/NRC World War II Veterans Twins Registry, the Agricultural Health Study, the Honolulu Asian Aging Study, the Alaska Native Medical Center, the legally-mandated California PD registry pilot project, the international LRRK2 PD-GEM study, the Chinese National Consortium on Neurodegenerative Diseases, the Shanghai Parkinson’s Study, the Shanghai Textile Workers Study, and the Bay Area Solvents Study.
Dr. Tanner is past co-chair of the Parkinson Study Group (PSG), and has conducted numerous clinical trials with the PSG, Neuroprotection Exploratory Trials in Parkinson’s Disease, and the Chinese Parkinson Study Group in China. Other research interests include work to facilitate collaborative research, including the NINDS Common Data Elements and the MDS Epidemiology Task Force, and work to identify PD-associated biomarkers in the Parkinson’s Progression Markers Initiative and the Longitudinal Assessment and Biomarkers Study of PD studies.
Dr. Tanner chairs the Epidemiology Task Force of the Movement Disorders Society, serves on the Executive Steering Committee of the NINDS PD Common Data Elements Committee, the Executive Council on the Sections and Subspecialties of the American Academy of Neurology and chairs several clinical trial data monitoring committees. She serves on the Scientific Advisory Boards of The Michael J. Fox Foundation and the National Spasmodic Dysphonia Association. Her honors include the Parkinson’s Disease Foundation Outstanding Woman Researcher (2004), the University of California-Berkeley Alumni Association Award for Excellence in Achievement (2008), and the American Academy of Neurology Movement Disorders Research Award (2012).
Fernando Pagan, MD (USA)
Carey Christensen (USA) is a patient activist, writer and speaker. Diagnosed with Parkinson's disease in 1999 at age 41, she turned to advocacy in 2002 after losing her job due to the little understood non-motor symptoms of PD.
As a voice for everyday patients struggling to maintain relationships, keep jobs, or get by on Social Security disability, Carey is motivated by her belief in the power of patient partnerships with researchers, doctors and the Parkinson’s community to help better understand, treat, cure, care and live well with PD. In addition to acting as a WPC 2016 Ambassador for the World Parkinson Coalition, she volunteers for the Michael J. Fox Foundation, the Parkinson's Action Network, the Northwest Parkinson's Foundation, and the Parkinson's Disease Foundation, working to raise awareness and provide insight as Parkinson's disease is redefined.
Carey is currently collaborating with her doctors, Monique Giroux, MD, and Sierra Farris, PA-C, at the Booth Gardner Parkinson's Care Center in Kirkland, Washington, to develop a wellness program that will help patients remain active. She lives near Seattle.
Patricia Davies (USA) has organized large international conferences for over 35 years. In 1991 she was recruited from her home country, the UK, for a position with the World Bank and the International Monetary Fund in Washington DC, where for 16 years she managed the joint Bank/Fund Annual and Spring Meetings.
Pat retired in 2007, and in 2009 she was diagnosed with Parkinson’s Disease. In 2010 she attended the World Parkinson Congress in Glasgow and was inspired to offer her services to assist. She is now a member of the WPC Steering Committee, and Advocates for Parkinson Committee, and is also Secretary of the Board of the World Parkinson Coalition.
Pat believes that staying as busy as possible is, for her, the best way of dealing with Parkinson’s Disease, and, among other things, she is very involved in working with homeless people in Washington DC. She is currently President of the Board of Georgetown Ministry Center, a day center for the homeless which is open 365 days a year and provides shower and laundry facilities, computers and medical and psychiatric help, as well as food and other kinds of support. She also helps to organize a winter shelter for the homeless, as well as a year-round Saturday night supper program.
Elizabeth Pollard (USA) has been with the World Parkinson Coalition from its inception in 2004 and helped steer the organization, alongside world renowned Parkinsonologist and WPC founder, Dr. Stanley Fahn. Together they worked to grow WPC Inc. from it's sole purpose, of hosting a triennial global Congress on Parkinson's disease, to it's more meaningful place in the community today, as a hub for many of the global PD organizations to connect and intersect online, on teleconferences, or in person at the Congresses. Eli is thrilled with the opportunity to meet the members of the community, to help build the WPC Legacy, and to watch as leading researchers, clinicians, people with Parkinson's and others work together to bring us closer to finding the cause(s) of Parkinson's and a cure for the disease.
Eli graduated from Michigan State University with a Bachelor's degree, and the School for International Training with a Master's degree in International & Intercultural Management. She spent most of her 20s living outside the US in Zimbabwe, Switzerland, and Japan with lengthy stays for research or travel in India, China, and Thailand. She lives in Brooklyn, New York with her husband and two rambunctious children who keep her on her toes when she's not knee deep in WPC work.
Karen Northrop (USA) has been a steadfast and loyal volunteer at the World Parkinson Coalition since 2008, by working with partnering organizations and serving on the Organization & Government Committee. More recently she’s been assisting in the effort to improve the WPC experience by using surveys to gather feedback and exploring possibilities for working with Rotary International. Her son Peter has early onset Parkinson’s making her interest in WPC a compelling one.
She retired in 2007 from her job as an audit director, specializing in computer security. In addition to computer systems in the New York metropolitan area, she reviewed systems at subsidiaries internationally. Prior to this, she taught high school math, and did financial auditing. She holds a bachelors degree in mathematics, a CPA, and an MBA.
Her volunteer work has included serving on the board for the Information Systems Security Association, taking part in an after school program for elementary school students, and tutoring in NYC high school math classes.